Ten-year mortality, disease progression, and treatment-related side effects in men with localised prostate cancer from the protecT randomised controlled trial according to treatment received

Ten-year mortality, disease progression, and treatment-related side effects in men with localised prostate cancer from the protecT randomised controlled trial according to treatment received

<p><strong>Background:</strong><br /> The ProtecT trial reported intention-to-treat analysis of men with localised prostate cancer (PCa) randomly allocated to active monitoring (AM), radical prostatectomy, and external beam radiotherapy.</p><br /> <p><st...

Full description

Bibliographic Details
Main Authors: Neal, D, Metcalfe, C, Donovan, J, Lane, J, Davis, M, Young, G, Dutton, S, Walsh, E, Martin, R, Peters, T, Turner, E, Mason, M, Bollina, P, Catto, J, Doherty, A, Gillatt, D, Gnanapragasam, V, Holding, P, Hughes, O, Kockelbergh, R, Kynaston, H, Oxley, J, Paul, A, Paez, E, Rosario, D, Rowe, E, Staffurth, J, Altman, D, Hamdy, F, Protect Study Group
Format: Journal article
Language:English
Published: Elsevier 2019

Similar Items